What is Missing in Treatment Guidelines?
作者信息
Carpenter William T
机构信息
University of Maryland School of Medicine, Department of Psychiatry, Maryland Psychiatric Research Center, Baltimore, MD, USA.
出版信息
Schizophr Bull. 2021 Mar 16;47(2):269-270. doi: 10.1093/schbul/sbaa194.
Abstract
摘要
相似文献
1
What is Missing in Treatment Guidelines?治疗指南中缺少了什么？
Schizophr Bull. 2021 Mar 16;47(2):269-270. doi: 10.1093/schbul/sbaa194.
2
Antipsychotic treatment of schizophrenia. We can do better.
Asian J Psychiatr. 2017 Aug;28:A1-A2. doi: 10.1016/j.ajp.2017.07.027.
3
Practice guidelines and combining atypical antipsychotics.实践指南与非典型抗精神病药物联合使用
Am J Psychiatry. 2004 Sep;161(9):1717-8. doi: 10.1176/appi.ajp.161.9.1717.
4
Antipsychotic treatment in the maintenance phase of schizophrenia: An updated systematic review of the guidelines and algorithms.抗精神病药物治疗精神分裂症维持期：指南和算法的更新系统评价。
Schizophr Res. 2020 Jan;215:8-16. doi: 10.1016/j.schres.2019.09.013. Epub 2019 Nov 26.
5
[Alteration of the guidelines on pharmaceuticals of the National Committee of Physicians and Health Insurers with regard to atypical neuroleptics. Statement of the German Scoiety of Psychiatry, Psychotherapy and Neurology (DGPPN)].[全国医师与健康保险商委员会关于非典型抗精神病药物的指南变更。德国精神病学、心理治疗与神经病学协会（DGPPN）声明]
Nervenarzt. 2003 Jan;74(1):97-9.
6
Schizophrenia practice guideline.精神分裂症实践指南。
Am J Psychiatry. 1997 Dec;154(12):1792; author reply 1793-4.
7
Consensus on early intervention in schizophrenia.精神分裂症早期干预的共识
Schizophr Bull. 2002;28(3):543-4. doi: 10.1093/oxfordjournals.schbul.a006962.
8
Schizophrenia practice guideline.精神分裂症实践指南。
Am J Psychiatry. 1997 Dec;154(12):1792-3; author reply 1793-4.
9
[Lifelong relapse prevention with antipsychotics in schizophrenia].[使用抗精神病药物对精神分裂症进行终身复发预防]
Psychiatr Prax. 2010 Sep;37(6):268-70. doi: 10.1055/s-0030-1248517. Epub 2010 Aug 27.
10
Optimising treatment of refractory schizophrenia.优化难治性精神分裂症的治疗
Psychopharmacology (Berl). 2013 May;227(2):373-4. doi: 10.1007/s00213-013-3076-y. Epub 2013 Apr 9.
引用本文的文献
1
Targeted Treatment of Schizophrenia Symptoms as They Manifest, or Continuous Treatment to Reduce the Risk of Psychosis Recurrence.针对精神分裂症症状的靶向治疗，或持续治疗以降低精神病复发风险。
Schizophr Bull. 2024 Jan 1;50(1):14-21. doi: 10.1093/schbul/sbad145.
本文引用的文献
1
The clinical characterization of the patient with primary psychosis aimed at personalization of management.原发性精神病患者的临床特征旨在实现管理的个性化。
World Psychiatry. 2021 Feb;20(1):4-33. doi: 10.1002/wps.20809.
2
Primary psychosis: more to know, much more to do.原发性精神病：要了解的更多，要做的更多。
World Psychiatry. 2021 Feb;20(1):1-2. doi: 10.1002/wps.20807.
3
The Hierarchical Taxonomy of Psychopathology (HiTOP): A dimensional alternative to traditional nosologies.精神病理学的分层分类法（HiTOP）：传统分类法的维度替代方案。
J Abnorm Psychol. 2017 May;126(4):454-477. doi: 10.1037/abn0000258. Epub 2017 Mar 23.
4
Bipolar and schizophrenia network for intermediate phenotypes: outcomes across the psychosis continuum.双相情感障碍和精神分裂症中间型网络：精神病连续体中的结局
Schizophr Bull. 2014 Mar;40 Suppl 2(Suppl 2):S131-7. doi: 10.1093/schbul/sbt179.
5
Comparative effectiveness of fluphenazine decanoate injections every 2 weeks versus every 6 weeks.每2周注射癸酸氟奋乃静与每6周注射癸酸氟奋乃静的比较疗效
Am J Psychiatry. 1999 Mar;156(3):412-8. doi: 10.1176/ajp.156.3.412.
6
Diazepam treatment of early signs of exacerbation in schizophrenia.
Am J Psychiatry. 1999 Feb;156(2):299-303. doi: 10.1176/ajp.156.2.299.
7
The diagnosis and understanding of schizophrenia. Part III. Speculations on the processes that underlie schizophrenic symptoms and signs.
Schizophr Bull. 1974 Winter(11):61-9. doi: 10.1093/schbul/1.11.61.
8
The diagnosis and understanding of schizophrenia. Part I. Use of signs and symptoms for the identification of schizophrenic patients.精神分裂症的诊断与理解。第一部分。运用体征和症状识别精神分裂症患者。
Schizophr Bull. 1974 Winter(11):37-49. doi: 10.1093/schbul/1.11.37.
Zotero 插件